A quantitative analysis of sedation in infants with caudal blockade

Organizational Data

DRKS-ID:
DRKS00005059
Recruitment Status:
Recruiting complete, study complete
Date of registration in DRKS:
2015-06-01
Last update in DRKS:
2016-07-11
Registration type:
Retrospective

Acronym/abbreviation of the study

/

URL of the study

http:///

Brief summary in lay language

Due to possible negative effects of anesthetic agents on the developing brain, we intend to analyse wether infants need sedation medication in conjunktion with a regional anesthesia at all. Infants (0-3 months age), who have to undergo lower body surgery in caudal anaesthesia, will be included. Comfort B Scale will be used to evaluate the depth of sedation and if there is a anaesthetic drug necessary at all. Two groups will be included. Group1 no anaesthetic drug (exept if required), Group2 will get a continuous infusion of Propofol 5mg/kg KG. Aim of the study is the total need of propofol doses in both groups.

Brief summary in scientific language

Infants and children undergoing anorectal, inguinal and lower extremity surgery do get a so called caudal block as anesthetic procedure of choice. It is the most commonly performed regional anesthesia in children and infants. For this well investigated regional anaesthetic technique the patient will be turned into the left lateral position and 1 ml/kg BW Ropivacaine 0.2% or 0.35% will be injected into the caudal space under aseptic conditions. According to the departmental standard and depending on the practical knowledge of the anesthetist, there is a possibility to monitor the spread of the lokal anesthetic into the epidural space using an ultrasound to ensure the correct injection of the LA18. Even though many institutions perform this regional anesthetic procedure in conjunction with general anesthesia, it is unclear wether the patients need anesthetic agents additionally at all. Based on our clinical experience and the suggestion that there is a possibility that the resaborption of the local anesthetic through the epidural space contributes a main part of the sedation effect, we perform this kind of regional procedure only with a light sedation using propofol in a dosage 5mg/kg BW. However, recently published studies suggest a negative effect of anesthetic agents on the developing brain particularly in infants. We therefore designed a study in order to analyse the level of sedation wether if there is a necessity of Propofol or not.

Health condition or problem studied

ICD10:
K40.9 - Unilateral or unspecified inguinal hernia, without obstruction or gangrene
Healthy volunteers:
No Entry

Interventions, Observational Groups

Arm 1:
Infants who will undergo lower body surgery in caudal anaesthesia, won't get a continuous infusion of propofol.
Arm 2:
Infants who will undergo lower body surgery in caudal anaesthesia, will get a continuous infusion of propofol in a dosage of 5mg/kg KG/h administered.

Endpoints

Primary outcome:
The main objective of the recent study is to investigate the need of additional anesthetic agents such as Propofol in children with caudal blockade undergoing lower body surgery. To evaluate the level of sedation we use the Comfort-B Skala19 ( a sedation score for children). The evaluation starts at skin incision by the surgery (every 10 minutes) until the transfer to the normal ward.
Secondary outcome:
/

Study Design

Purpose:
Treatment
Allocation:
Randomized controlled study
Control:
  • Active control (effective treatment of control group)
Phase:
N/A
Study type:
Interventional
Mechanism of allocation concealment:
No Entry
Blinding:
Yes
Assignment:
Parallel
Sequence generation:
No Entry
Who is blinded:
  • Data analyst

Recruitment

Recruitment Status:
Recruiting complete, study complete
Reason if recruiting stopped or withdrawn:
No Entry

Recruitment Locations

Recruitment countries:
  • Austria
Number of study centers:
Monocenter study
Recruitment location(s):
  • University medical center Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie Wien

Recruitment period and number of participants

Planned study start date:
No Entry
Actual study start date:
2013-10-01
Planned study completion date:
No Entry
Actual Study Completion Date:
2015-10-07
Target Sample Size:
34
Final Sample Size:
34

Inclusion Criteria

Sex:
All
Minimum Age:
0 Months
Maximum Age:
3 Months
Additional Inclusion Criteria:
- Infants aged between 0 and 3 months - Lower body surgery with planned caudal blockade - Written informed consent given by parents after being provided with detailed information about the nature, risks, and scope of the clinical study

Exclusion Criteria

- Parents refusal - Contraindications against a caudal blockade - Coagulopathy

Addresses

Primary Sponsor

Address:
Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
Univ.- Prof. Dr. Klaus Markstaller
Währinger Gürtel 18-20
1090 Wien
Austria
Telephone:
00 43 1 40400 4100
Fax:
00 43 1 40400 4028
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.meduniwien.ac.at
Investigator Sponsored/Initiated Trial (IST/IIT):
Yes

Contact for Scientific Queries

Address:
AKH Wien
Dr.med.univ Wolfgang Klug
Währinger Gürtel 18-20
1090 Wien
Austria
Telephone:
0043 1 19231
Fax:
0043 1 19256
Contact per E-Mail:
Contact per E-Mail
URL:
http://meduniwien.ac.at

Contact for Public Queries

Address:
AKH Wien
Dr.med.univ Wolfgang Klug
Währinger Gürtel 18-20
1090 Wien
Austria
Telephone:
0043 1 19231
Fax:
0043 1 19256
Contact per E-Mail:
Contact per E-Mail
URL:
http://meduniwien.ac.at

Principal Investigator

Address:
AKH Wien
Dr.med.univ Wolfgang Klug
Währinger Gürtel 18-20
1090 Wien
Austria
Telephone:
0043 1 19231
Fax:
0043 1 19256
Contact per E-Mail:
Contact per E-Mail
URL:
http://meduniwien.ac.at

Sources of Monetary or Material Support

Institutional budget, no external funding (budget of sponsor/PI)

Address:
Anästhesie, Allgemeine Intensivmedizin und Schmerztherapie
Währinger Gürtel 18-20
1090 Wien
Austria
Telephone:
00 43 1 40400 4100
Fax:
00 43 1 40400 4028
Contact per E-Mail:
Contact per E-Mail
URL:
http://www.meduniwien.ac.at

Ethics Committee

Address Ethics Committee

Address:
Ethikkommission der Medizinischen Universität Wien
Borschkegasse 8b/E06
1090 Wien
Germany
Telephone:
(+43)1-40400-21470
Fax:
No Entry
Contact per E-Mail:
Contact per E-Mail
URL:
No Entry

Vote of leading Ethics Committee

Vote of leading Ethics Committee
Date of ethics committee application:
2013-09-03
Ethics committee number:
1697/2013
Vote of the Ethics Committee:
Approved
Date of the vote:
2013-09-24

Further identification numbers

Other primary registry ID:
No Entry
EudraCT Number:
No Entry
UTN (Universal Trial Number):
No Entry
EUDAMED Number:
No Entry

IPD - Individual Participant Data

Do you plan to make participant-related data (IPD) available to other researchers in an anonymized form?:
No Entry
IPD Sharing Plan:
No Entry

Study protocol and other study documents

Study protocols:
No Entry
Study abstract:
No Entry
Other study documents:
No Entry
Background literature:
No Entry
Related DRKS studies:
No Entry

Publication of study results

Planned publication:
No Entry
Publikationen/Studienergebnisse:
No Entry
Date of first publication of study results:
No Entry
DRKS entry published for the first time with results:
No Entry

Basic reporting

Basic Reporting / Results tables:
No Entry
Brief summary of results:
No Entry